Article: NeoGenomics Reports Third Quarter 2009 Results.

FT. MYERS, Fla., Oct. 29 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.

 
  Highlights: 
  --  Revenue increase of  44% versus Q3 08 to $7.3 million 
  --  Build-out of  a full-service melanoma laboratory and commencement of a 
  large melanoma validation study 
  --  Significantly improved liquidity position 
 
  --  Douglas VanOort appointed Chief Executive Officer 
 
 

Revenue increased by $2.2 million or 44% to $7.3 million in the third quarter from $5.1 million in the same quarter last year. The number of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!